IL6 and COVID-19: Since severe COVID-19 patients show high expression of TLR4 in PBMCs (133), we can speculate that the activation of this receptor by LPS derived from the gut microbiota of elderly, diabetic, and hypertensive individuals would also potentiate the production of IL-6 induced by SARS-CoV-2.